اَخر الأخبار
Mankind Pharma net profit drops 16% to Rs 385 crore in Q3FY25
Mankind Pharma's Q3 FY25 net profit declined 16% YoY to ₹385 crore despite a 24% revenue increase to ₹3,230 crore. Domestic revenues rose 17%, exports more than doubled, and consumer health grew 30%.
For more details: Click here